Status: Recruiting
(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000
This study will measure how well PathFinder 1.0 detects retinal abnormalities on macular cube OCT B-scans by assessing its sensitivity and specificity.
Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Carl Zeiss Meditec-Dublin CoCeUpdated: Jul 2, 2026Locations: 6
Eligibility criteria
Able and willing to make the required study visits. [+10]
Inability to undergo the required tests. [+6]